Menu

Publikationen

 

Klinische Publikationen

  • Nitsch N, Napiletzki K, Stope MB (2022) Non-invasive physical plasma (NIPP) treatment of a hedgehog with head injury - a novel therapy in veterinary medicine. Vet Record Case Rep 10:e343
  • Recker F, Dohmen S, Egger EK, Stope MB, Dimitrova D, Könsgen D, Ritter M, Sehouli J, Gadebusch Bondio M, Mustea A (2021) Impact of COVID‑19 on gynaecological patient care: results of patient’s survey with 327 patients. Arch Gynacol Obstet 305:389-395
  • Mao X, Lei H, Yi T, Su P, Tang S, Tong Y, Dong B, Ruan G, Mustea A, Sehouli J, Sun P (2022) Lipid reprogramming induced by the TFEB-ERRα axis enhanced membrane fluidity to promote EC progression. J Exp Clin Cancer Res 41:28
  • Woelber L, Hampl M, Eulenburg CZ, Prieske K, Hambrecht J, Fuerst S, Klapdor R, Heublein S, Gass P, Rohner A, Canzler U, Becker S, Bommert M, Bauerschlag D, Denecke A, Hanker L, Runnebaumn I, Forner DM, Schochter F, Klar M, Schwab R, Koepke M, Kalder M, Hantschmann P, Ratiu D, Denschlag D, Schroeder W, Tuschy B, Baumann K, Mustea A, Soergel P, Bronger H, Bauerschmitz G, Kosse J, Koch MC, Ignatov A, Sehouli J, Dannecker C, Mahner S, Jaeger A (2022) Risk for pelvic metastasis and role of pelvic lymphadenectomy in node-positive vulvar cancer - Results from the AGO-VOP.2 QS vulva study. Cancers 14:418
  • COVIDSurg Collaborative; GlobalSurg Collaborative (2022). SARS-CoV-2 infection and venous thromboembolism after surgery: An international prospective cohort study. Anaesthesia 77:28-39
  • Condic M, Mustea A, Ralser DJ, Wenzel J, Braegelmann C (2022) Severe leukoplakia of the vagina and cervix successfully treated with intravaginal application of topical glucocorticoids. Arch Clin Med Case Rep 6:63-65
  • Hecking T, Thiesler T, Halbei J, Otten L, Recker F, Gevensleben H, Müller T, Schiller C, Egger EK, Fimmers R, Stope MB, Kristiansen G, Mustea A (2022) Programmed cell death ligand-1 (PDL-1) correlates with tumor infiltration by immune cells and represents a promising target for immunotherapy in endometrial cancer. Anticancer Res 42:1367-1376
  • Eggers B, Stope MB, Mustea A, Nokhbehsaim M, Heim N, Kramer FJ (2022) Non-invasive physical plasma treatment after tooth extraction in a patient on antiresorptive medication promotes tissue regeneration. Appl Sci 12:3490
  • Dejonckheere CS, Torres-Crigna A, Layer JP, Layer K, Wiegreffe S, Sarria GR, Scafa D, Koch D, Leitzen C, Köksal MA, Müdder T, Abramian A, Kaiser C, Faridi A, Stope MB, Mustea A, Giordano FA, Schmeel LC (2022) Non-invasive physical plasma for preventing radiation dermatitis in breast cancer: a first-in-human feasibility study. Pharmaceutics 14:1767
  • Egger E, Merker F, Ralser R, Condic M, Marinova M, Muders M, Stope MB, Mustea A (2022) Tumor load matters – the Peritoneal Cancer Index in patients with high-grade serous ovarian cancer. Anticancer Res 42:4825-4831

  • Harter P, Sehouli J, Vergote I, Ferron G, Reuss A, Meier W, Greggi S, Mosgard BJ, Selle F, Guyon F, Pomel C, Lécuru F, Zang R, Avall-Lundqvist E, Kim JW, Ponce J, Raspagliesi F, Kristensen G, Classe JM, Hillemanns P, Jensen P, Hasenburg A, Ghaem-Maghami S, Mirza MR, Lund B, Reinthaller A, Santaballa A, Olaitan A, Hilpert F, du Bois A; DESKTOP III Investigators (2021) Randomized trial of cytoreductive surgery for relapsed ovarian cancer. N Engl J Med 385:2123-2131
  • Mallmann CA, Domröse CM, Schröder L, Engelhardt D, Bach F, Rueckel H, Abramian A, Kaiser C, Mustea A, Faridi A, Malter W, Mallmann P, Rudlowski C, Zivanovic O, Mallmann MR (2021) Digital technical and informal resources   of breast cancer patients from 2012 to 2020: Questionnaire-based longitudinal trend study. JMIR Cancer 7:e20964
  • Recker F, Thudium M, Strunk H, Tonguc T, Dohmen S, Luechters G, Bette B, Welz S, Salam B, Wilhelm K, Egger EK, Wüllner U, Attenberger U, Mustea A, Conrad R, Marinova M (2021) Multidisciplinary management to optimize outcome of ultrasound-guided high-intensity focused ultrasound (HIFU) in patients with uterine fibroids. Sci Rep 11:22768.
  • Woelber L, Prieske K, Eulenburg C, Oliveira-Ferrer L, DE Gregorio N, Klapdor R, Kalder M, Braicu I, Fuerst S, Klar M, Straub HG, Beckmann M, Meier W, Ignatov A, Mustea A, Jueckstock J, Schmidt G, Bauernschlag D, Hellriegel M, Canzler U, Petry KU, Kommoss S, Hantschmann P, Heubner M, Mahner S, Burandt E (2021) p53 and p16 expression profiles in vulvar cancer - a translational analysis by the AGO-CaRE- study group. Am J Obstet Gynecol 224:595.e1-595.e11
  • COVIDSurg Collaborative, GlobalSurg Collaborative (2021) SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study. Br J Surg 108:1056-106
  • COVIDSurg Collaborative; GlobalSurg Collaborative (2021) Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study. Anaesthesia 76:1454-1464
  • Ansmann L, Heuser C, Diekmann A, Schellenberger B, Biehl C, Danaei M, Eichler C, Heinz D, Hocke A, Malter W, Melekian B, Metin H, Mustea A, Palatty J, Peisker U, Petschat I, Ernstmann N (2021) Patient participation in multidisciplinary tumor conferences: How is it implemented? What is the patients' role? What are patients' experiences? Cancer Med 10:6714-6724
  • Armbrust R, Chen F, Richter R, Muallem MZ, Mustea A, Holthaus B, Sehouli J (2021) Results of a German wide survey towards current surgical approach in early stage cervical cancer NOGGO MONITOR 11. Sci Rep 11:9774
  • Woelber L, Bommert M, Harter P, Prieske K, Zu Eulenburg C, Jueckstock J, Hilpert F, de Gregorio N, Iborra S, Sehouli J, Ignatov A, Hillemanns P, Fuerst S, Strauss HG, Baumann K, Beckmann M, Mustea A, Meier W, Mahner S, Jaeger A (2021) Role of Pelvic Lymph Node Resection in Vulvar Squamous Cell Cancer: A Subset Analysis of the AGO-CaRE-1 Study. Ann Surg Oncol 28:6696-6704
  • Sehouli J, Mustea A, Oskay-Özcelik G, Keller M, Richter R, Tome O, Woopen H, Sommer-Joos AK, Grabowski JP, Armbrust R, Wimberger P (2021) Bevacizumab combined with platinum-taxane chemotherapy as first-line treatment for advanced ovarian cancer: Results of the NOGGO non-interventional study (OTILIA) in 824 patients. Cancers 13:4739
  • Marinova M, Ghaei S, Recker F, Tonguc T, Kaverina O, Savchenko O, Kravchenko D, Thudium M, Pieper CC, Egger EK, Mustea A, Attenberger U, Conrad R, Hadizadeh DR, Strunk H (2021) Efficacy of ultrasound-guided high-intensity focused ultrasound (USgHIFU) for uterine fibroids: an observational single-center study. Int J Hyperthermia 38:30-38
  • Tonguc T, Strunk H, Gonzalez-Carmona MA, Recker F, Lütjohann D, Thudium M, Conrad R, Becher MU, Savchenko O, Davidova D, Luechters G, Mustea A, Strassburg CP, Attenberger U, Pieper CC, Jenne J, Marinova M (2021) US-guided high-intensity focused ultrasound (HIFU) of abdominal tumors: outcome, early ablation-related laboratory changes and inflammatory reaction. A single-center experience from Germany. Int J Hyperthermia 38:65-74
  • Rüdiger R, Geiser F, Ritter M, Brossart P, Keyver-Paik MD, Faridi A, Vatter H, Bootz F, Landsberg J, Kalff JC, Herrlinger U, Kristiansen G, Pietsch T, Aretz S, Thomas D, Radbruch L, Kramer FJ, Strassburg CP, Gonzalez-Carmona M, Skowasch D, Essler M, Schmid M, Nadal J, Ernstmann N, Sharma A, Funke B, Schmidt-Wolf IGH (2021) No evidence to support the impact of migration background on treatment response rates and cancer survival: a retrospective matched-pair analysis in Germany. BMC Cancer 21:526
  • Egger EK, Liesenfeld H, Stope MB, Recker F, Döser A, Marinova M, Könsgen D, Hilbert T, Exner D, Ellinger J, Mustea A (2021) Pelvic exenteration in advanced gynecologic malignancies - who will benefit? Anticancer Res 41:3037-3043
  • Egger EK, Ralser DJ, Lindner K, Recker F, Marinova M, Savchenko O, Lau JF, Mustea A (2021) Diagnostic and Therapeutic Approach in a Metastatic Vaginal Adenocarcinoma: A Case Report. Front Immunol 12:686879
  • COVIDSurg Collaborative; GlobalSurg Collaborative (2021) Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia 76:748-758
  • Prieske K, Woelber L, Muallem MZ, Eulenburg C, Jueckstock JK, Hilpert F, de Gregorio N, Iborra S, Ignatov A, Hillemanns P, Fuerst S, Strauss HG, Baumann K, Beckmann M, Mustea A, Meier W, Harter P, Wimberger P, Sehouli J, Mahner S (2021) Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 study. Gynecol Oncol 161:442-448
  • Kamal M, Lameiras S, Deloger M, Morel A, Vacher S, Lecerf C, Dupain C, Jeannot E, Girard E, Baulande S, Dubot C, Kenter G, Jordanova ES, Berns EMJJ, Bataillon G, Popovic M, Rouzier R, Cacheux W, Le Tourneau C, Nicolas A, Servant N, Scholl SM, Bièche I; RAIDs Consortium (2021) Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site. Br J Cancer 124:777-785
  • Kinnen A, Klaschik S, Neumann C, Egger EV, Mustea A, Soehle M, Frede S, Velten M, Coburn M, Hilbert T (2021) Gene expression in the Angiopoietin/TIE axis is altered in peripheral tissue of ovarian cancer patients: A prospective observational study. Life Sciences 274:119345
  • Erben P, Becker C, Tsaur I, Stope MB, Todenhöfer T (2021) Molecular subtypes of urothelial carcinoma of the bladder-background and clinical relevance. Urologe A 60:81-88
  • Egger EK, Stope MB, Recker F, Könsgen D, Landsberg J, Fröhlich A, Abramian A, Mustea A (2021) Lower genital tract melanomas: Staging, predictors of outcome and new therapeutic options. Anticancer Res 41:999-1004
  • Abazid A, Holstein N, Machemehl T, Stope MB, Hauer T (2021) Das Zebra unter den Divertikulitiden. Der Chirurg 92:374-376
  • Gelbrich N, Stope MB, Bekeschus S, Weigel M, Burchardt M, Zimmermann U (2020) BK virus-induced nephritis and cystitis after matched unrelated donor stem cell transplantation: a case report. Clin Case Rep 8:2838–2841
  • Recker F, Weber E, Strizek B, Gembruch U, Seibel A (2020) Lung Sonography in Obstetrics during COVID-19. Geburtshilfe Frauenheilkd 80:1026–1032
  • Emons G, Mustea A, Tempfer C (2020) Tamoxifen and endometrial cancer: a Janus-headed drug. Cancers 12:2535
  • Marnitz S, Tsunoda AT, Martus P, Vieira M, Affonso RJ, Nunes J, Budach V, Hertel H, Mustea A, Sehouli J, Scharf JP, Ulrich U, Ebert A, Piwonski I, Kohler C (2020) Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study. Int J Gynecol Cancer 30:1855-1861
  • Woelber L, Bommert M, Prieske K, Fischer I, Zu Eulenburg C, Vettorazzi E, Harter P, Jueckstock J, Hilpert F, de Gregorio N, Iborra S, Sehouli J, Ignatov A, Hillemanns P, Fuerst S, Strauss HG, Baumann K, Beckmann M, Mustea A, Meier W, Wimberger P, Hanker L, Canzler U, Fehm T, Luyten A, Hellriegel M, Kosse J, Heiss C, Hantschmann P, Mallmann P, Tanner B, Pfisterer J, Mahner S, Schmalfeldt B, Jaeger A (2020) Pelvic Lymphadenectomy in Vulvar Cancer - Does it make sense? Geburtshilfe Frauenheilkd 80:1221-1228
  • Marnitz S, Waltar T, Köhler C, Mustea A, Schömig-Markiefka B (2020) The brave new world of endometrial cancer: Future implications for adjuvant treatment decisions. Strahlenther Onkol 196:963-972
  • Egger EK, Kohls N, Stope MB, Condic M, Keyver-Paik MD, Könsgen D, Hilbert T, Klaschik S, Exner D, Vilz T, Mustea A (2020) Risk factors for severe complications in ovarian cancer surgery. In Vivo 34:3361-3365
  • Ralser DJ, Strizek B, Kupczyk P, Stoffel-Wagner B, Altengarten J, Müller A, Woelfle J, Gembruch U, Klingmueller D, Merz WM, Paschkowiak-Christes A (2020) Obstetric and neonatal outcome of pregnancy in carney complex: A case report. Front Endocrinol 11:296
  • Fröhlich A, Niebel D, Fietz S, Egger E, Buchner A, Sirokay J, Landsberg J (2020) Talimogene laherparepvec treatment to overcome loco-regional acquired resistance to immune checkpoint blockade in tumor stage IIIB-IV M1c melanoma patients. Cancer Immunol Immunother 69:759-769
  • Hoffmann B, Blaivas M, Abramowicz JS, Bachmann Nielsen M, Badea R, Braden B, Cantisani V, Chammas MC, Cui XW, Dong Y, Gilja OH, Hari R, Lamprecht H, Nisenbaum H, Nolsøe CP, Nürnberg D, Prosch H, Radzina M, Recker F, Sachs A, Saftoiu A, Serra A, Vinayak S, Westerway S, Chou YH, Dietrich CF (2020) Medical Student Ultrasound Education, a WFUMB Position Paper, Part II. A consensus statement by ultrasound societies. Med Ultrason 22:220-229
  • Klapdor R, Hillemanns P, Wölber L, Jückstock J, Hilpert F, de Gregorio N, Hasenburg A, Sehouli J, Fürst S, Strauss H, Baumann K, Thiel F, Mustea A, Meier W, Harter P, Wimberger P, Hanker L, Schmalfeld B, Mahner S (2020) Association between obesity and vulvar cancer recurrence: an analysis of the AGO-CaRE-1 study. Int J Gynecol Cancer 30:920-926
  • Scheck M, Velten M, Klaschik S, Soehle M, Frede S, Gehlen J, Hoch J, Mustea A, Hoeft A, Hilbert T (2020) Differential modulation of endothelial cell function by fresh frozen plasma. Life Sci 254:117780
  • Strizek B, Gottschalk I, Recker F, Weber E, Flöck A, Gembruch U, Geipel A, Berg C (2020) Vesicoamniotic shunting for fetal megacystis in the first trimester with a  Somatex intrauterine shunt. Arch Gynecol Obstet 302:133-140
  • Fröhlich A, Hoffmann F, Niebel D, Egger E, Kukuk GM, Toma M, Sirokay J, Bieber T, Landsberg J (2020) Talimogene Laherparepvec in Advanced Mucosal Melanoma of the Urethra Upon Primary Resistance on Immune Checkpoint Inhibition: A Case Report. Frontiers in Oncology 10:611
  • Gehlen J, Klaschik S, Neumann C, Keyver-Paik MD, Mustea A, Soehle M, Frede S, Velten M, Hoeft A, Hilbert T (2020) Dynamic changes of angiopoietins and endothelial nitric oxide supply during fluid resuscitation for major gyn-oncological surgery: a prospective observation. J Transl Med 18:48
  • Kramer A, Meinke M, Patzelt A, Stope MB, Lademann J, Jacobs K (2020) Perspektiven physikalischer Verfahren der Antiseptik und Desinfektion. Hygiene & Medizin 45:39-45
  • Klinkmann G, Stope MB, Meyer A (2020) Cytokine adsorption as a promising option for septic shock and multiple organ failure due to Candida infection and decompensated type 1 diabetes mellitus. Artif Organs 44:522-525
  • Harter P, Sehouli J, Lorusso D, Reuss A, Vergote I, Marth C, Kim JW, Raspagliesi F, Lampe B, Aletti G, Meier W, Cibula D, Mustea A, Mahner S, Runnebaum IB, Schmalfeldt B, Burges A, Kimmig R, Scambia G, Greggi S, Hilpert F, Hasenburg A, Hillemanns P, Giorda G, von Leffern I, Schade-Brittinger C, Wagner U, du Bois A (2019) A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms. N Engl J Med 380:822-832
  • Mustea A, Holthaus B, Elmeligy H, Krüger-Rehberg S, Trojnarska D, Alwafai Z, Sternberg J, Stope MB, Kohlmann T, Meinhold-Heerlein I, Koensgen D (2019) Comparison of laparoscopy-assisted vaginal hysterectomy as endoscopic single-station surgery and conventional laparoscopic hysterectomy - surgical effects on safety and quality of life. Gynecol Surg 16:9
  • Riedel F, Weiss M, Stope MB (2019) Neue Möglichkeiten in der gynäkologischen Onkologie - kaltes physikalisches Plasma. Gynäkologe 52:144-146
  • Bailer B, Recker F, Matuschek E (2019) Basiswissen PoCUS - Point-of-Care-Ultraschall lernen und sinnvoll einsetzen. Thieme Verlag. 1. Aufl. ISBN: 9783132426962
  • Klaschik S, Gehlen J, Neumann C, Keyver-Paik MD, Soehle M, Frede S, Velten M, Hoeft A, Hilbert T (2019) Network of mediators for vascular inflammation and leakage is dysbalanced during cytoreductive surgery for late-stage ovarian cancer. Mediators Inflamm 2019:5263717
  • Budde MK, Kuhn W, Keyver-Paik MD, Bootz F, Kalff JC, Müller SC, Bieber T, Brossart P, Vatter H, Herrlinger U, Wirtz DC, Schild HH, Kristiansen G, Pietsch T, Aretz S, Geiser F, Radbruch L, Reich RH, Strassburg CP, Skowasch D, Essler M, Ernstmann N, Landsberg J, Funke B, Schmidt-Wolf IGH (2019) A matched-pair analysis on survival and response rates between German and non-German cancer patients treated at a Comprehensive Cancer Center. BMC Cancer 19:1024
  • Dietrich CF, Hoffmann B, Abramowicz J, Badea R, Braden B, Cantisani, V, Chammas MC, Cui XW, Dong Y, Gilja OH, Hari R, Nisenbaum H, Nicholls D, Nolsoe CP, Nürnberg D, Prosch H, Radzina M, Recker F, Sachs A, Saftoiu A, Serra A, Sweet L, Vinayak S, Westerway S, Chou YH, Blaivas M (2019) Medical student ultrasound education: A WFUMB position paper, part I. Ultrasound Med Biol 45:271-281
  • Gelbrich N, Stope MB, Waldburger N, Breitsprecher R, Burchardt M, Zimmermann U (2019) Muscle invasive urinary bladder squamous cell carcinoma in a patient with clean intermittent self-catheterization: A case report. J Urol Ren Dis 4:1168
  • Polterauer S, Schwameis R, Grimm C, Hillemanns P, Jückstock J, Hilpert F, de Gregorio N, Hasenburg A, Sehouli J, Fürst ST, Strauß HG, Baumann K, Thiel F, Mustea A, Harter P, Wimberger P, Kölbl H, Reinthaller A, Woelber L, Mahner S (2019) Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study. Gynecol Oncol 153:286-291
  • Fischer J, Stope MB (2019) Euthanasia and resuscitation in clinical everyday life - an ethical view from a deontological and consequentialist perspective. Am J Pallia Med Care 1:1-3
  • Schmalfeldt B, Brambs C, Burges A, El-Balat A, Emons G, Fink D, Fotopoulou C, Gropp-Meier M, Hanker LC, Harter P, Hasenburg A, Hauptmann S, Hilpert F, Kimmig R, Kommoss S, Kurzeder C, Mahner S, Marmé F, Mayr D, Meier W, Meinhold-Heerlein I, Mustea A, Ortmann O, Oskay-Özcelik G, Pfisterer J, Pölcher M, Runnebaum IB, Schröder W, Tanner B, Wagner U, Wimberger P, Sehouli J (2019) What is the evidence for lymphadenectomy in presumed early ovarian cancer? Arch Gynecol Obstet 299:1-5
  • Koscielny A, Ko A, Egger EK, Kuhn W, Kalff JC, Keyver-Paik MD (2019) Prevention of anastomotic leakage in ovarian cancer debulking surgery and its impact on overall survival. Anticancer Res 39:5209-5218
  • Fischer J, Stope MB, Gümbel D, Hakenberg O, Burchardt M, Dräger DL (2019) Einfluss von Kultur und Religion auf die Therapie von Krebspatienten. Urologe A 58:1179-1184
  • Denschlag D, Ackermann S, Battista MJ, Cremer W, Egerer G, Follmann M, Haas H, Harter P, Hettmer S, Horn LC, Juhasz-Boess I, Kast K, Köhler G, Kröncke T, Lindel K, Mallmann P, Meyer-Steinacker R, Mustea A, Petru E, Reichardt P, Schmidt D, Strauss HG, Tempfer C, Thiel F, Ulrich U, Vogl T, Vordermark D, Gass P, Beckmann MW (2019) Sarcoma of the uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019). Geburtshilfe Frauenheilkd 79:1043-1060
  • Gelbrich N, Stope MB, Burchardt M (2019) Kaltes atmosphärisches Plasma für die urologische Tumortherapie. Urologe A 58:673-679
  • Emons G, Tempfer C, Battista MJ, Mustea A, Vordermark D (2019) Uterus Commission of the AGO adjuvant radiotherapy and/or chemotherapy for endometrial cancer, status as at 2019: Opinion of the Uterus Commission of the Gynecological Oncology Working Group (AGO). Geburtshilfe Frauenheilkd 79:1273-1277
  • Welz J, Keyver-Paik MD, Gembruch U, Merz WM (2019) Self-reported physical, mental, and reproductive sequelae after treatment of abnormally invasive placenta: a single-center observational study. Arch Gynecol Obstet 300:95-101
  • Gelbrich N, Stope MB (2019) Physikalisches Plasma in der chirurgischen Uroonkologie. Krankenhaus und Management 38:9
 

Translationale experimentelle Publikationen

  • Singer D, Ressel V, Stope MB, Bekeschus M (2022) Heat shock protein 27 affects myeloid cell activation and interaction. Biomedicines 10:2192
  • Eggers B, Stope MB, Marciniak J, Götz W, Mustea A, Deschner J, Nokhbehsaim M, Kramer FJ (2022) Non-invasive physical plasma generated by a medical argon plasma device induces the expression of regenerative factors in human gingival keratinocytes, fibroblasts, and tissue biopsies. Biomedicines 10:889
  • Haralambiev L, Nitsch A, Fischer CS, Lange A, Klöting I, Stope MB, Ekkernkamp A, Lange J (2022) Increase in bone mass before onset of type 1 diabetes mellitus in rats. In Vivo 36:1077-1082 
  • Siciliano T, Sommer U, Beier AMK, Stope MB, Borkowetz A, Thomas C, Erb HHH (2022) The androgen hormone-induced increase in androgen receptor protein expression is caused by the autoinduction of the androgen receptor translational activity. Curr Issues Mol Biol 44:597-608
  • Bekeschus S, Ispirjan M, Freund E, Kinnen F, Moritz J, Saadati F, Eckroth J, Singer D, Stope MB, Wende K, Ritter CA, Schroeder HWS, Marx S (2022) Gas plasma technology targeting of glioblastoma multiforme (GBM) in vitro and patient-derived tumor tissues. Cancers 14:813
  • Sommer U, Siciliano T, Ebersbach C, Beier AMK, Stope MB, Jöhrens K, Baretton GB, Borkowetz A, Thomas C, Erb HHH (2022) Impact of androgen receptor-mediated gene transactivation on prostate-specific membrane antigen expression in prostate cancer cells. Int J Mol Sci 23:1046
  • Gelbrich N, Burchardt M, Zimmermann U, Stope MB, Bekeschus S (2022) Antineoplastische Effekte von kaltem physikalischen Plasma. Uro-News 26:14–19
  • Erb HHH, Streitbörger A, Mustea A, Stope MB (2022) Physiological and genetically engineered expression modulation methods do not affect cellular levels of the heat shock protein HSP60 in prostate cancer cells. In Vivo 36:596-602
  • Eggers B, Stope MB, Marciniak J, Mustea A, Deschner J, Nokhbehsaim M, Kramer FJ (2022) Modulation of inflammatory responses by a non-invasive physical plasma jet during gingival wound healing. Cells 11:2740
  • Hermasch MA, Janning H, Perera RP, Schnabel V, Rostam N, Ramos-Gomes F, Muschalek W, Bennemann A, Alves F, Ralser DJ, Betz RC, Schön MP, Dosch R, Frank J (2022) Evolutionary distinct roles of γ-secretase subunit nicastrin in zebrafish and humans. J Dermatol Sci105:80-87
  • Nitsch A, Strakeljahn S, Jacoby JM, Sieb K, Mustea A, Bekeschus S, Ekkernkamp A, Stope MB, Haralambiev L (2022) New approach against chondrosoma cells - cold plasma treatment inhibits cell motility and metabolism, and leads to apoptosis. Biomedicines 10:688
  • Marzi J*, Stope MB*, Henes M, Koch A, Wenzel T, Holl M, Layland SL, Neis F, Bösmüller H, Ruoff F, Templin M, Krämer B, Staebler A, Barz J, Carvajal Berrio DA, Enderle M, Loskill P, Brucker SY, Schenke-Layland K, Weiss M (2022) Non-invasive physical plasma (NIPP) as innovative and tissue-preserving therapy for women positive for cervical intraepithelial neoplasia. Cancers 14:1933
  • Klümper N, Ralser DJ, Zarbl R, Schlack K, Schrader AJ, Rehlinghaus M, Hoffmann MJ, Niegisch G, Uhlig A, Trojan L, Steinestel J, Steinestel K, Wirtz RM, Sikic D, Eckstein M, Kristiansen G, Toma M, Hölzel M, Ritter M, Strieth S, Ellinger J, Dietrich D (2021) CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma. J Immunother Cancer 9:e002949
  • Sander C, Nitsch A, Erb HHH, Egger EK, Haralambiev L, Eggers B, Kramer FJ, Weiss M, Mustea A, Stope MB (2021) Non-invasive physical plasma enhances the membrane permeability to low molecular weight compounds and subsequently leads to the loss of cellular ATP and the devitalization of epithelial cancer cells. Appl Sci 11:9801
  • Gelbrich N, Burchardt M, Zimmermann U, Stope MB, Bekeschus S (2021) Kaltes atmosphärisches Plasma: Neue Behandlungsoption für Harnblasenkrebs. UroForum 9/2021:26-28
  • Schütz CS, Stope MB, Bekeschus S (2021) H2A.X phosphorylation in oxidative stress and risk assessment in plasma medicine. Oxid Med Cell Longev 2021:2060986
  • Nitsch A, Stope MB (2021) The future therapy of renal cell carcinoma? Non-invasive physical plasma as an innovative oncological therapy modality. J Cancer Ther 12:602-610
  • Ralser DJ, Klümper N, Gevensleben H, Zarbl R, Kaiser C, Landsberg J, Hölzel M, Strieth S, Faridi A, Abramian A, Dietrich D (2021) Molecular and Immune Correlates of PDCD1 (PD-1), PD-L1 (CD274), and PD-L2 (PDCD1LG2) DNA Methylation in Triple Negative Breast Cancer. J Immunother 44:319-324
  • Eggers B, Marciniak J, Deschner J, Stope MB, Mustea A, Kramer FJ, Nokhbehsaim M (2021) Cold atmospheric plasma promotes regeneration-associated cell functions of murine cementoblasts in vitro. Int J Mol Sci 22:5280
  • Erb HHH, Culig Z, Stope MB (2021) IL-4 Counteracts the Cytotoxic Effects of PBMC on Hormone-sensitive Prostate Cancer Cells. In Vivo 35:1973-1977
  • Erb HHH, Oster MA, Gelbrich N, Cammann C, Thomas C, Mustea A, Stope MB (2021) Enzalutamide-induced proteolytic degradation of the androgen receptor in prostate cancer cells is mediated only to a limited extent by the proteasome system. Anticancer Res 41:3271-3279
  • Oelrich F, Junker H, Stope MB, Erb HHH, Walther R, Venz S, Zimmermann U (2021) Gelsolin governs the neuroendocrine transdifferentiation of prostate cancer cells and suppresses the apoptotic machinery. Anticancer Res 41:3717-3729
  • Siciliano T, Simons IH, Beier AMK, Ebersbach C, Aksoy C, Seed RI, Stope MB, Thomas C, Erb HHH (2021) Systematic comparison of antiandrogens identifies androgen receptor protein stability as an indicator for treatment response. Life 11:874
  • Tsaur I, Erben P, Stope MB, Becker C, Todenhöfer T (2021) Fachgruppe „Molekulare Urologie“ der „Arbeitsgruppe urologische Forschung“ der DGU. Spectrum Urologie 1/2021: 22-23
  • Freud E, Miebach L, Stope MB, Bekeschus S (2021) Hypochlorous acid selectively promotes toxicity and the expression of danger signals in human abdominal cancer cells. Oncol Rep 45:71
  • Stope MB (2021) Phosphorylation of histone H2A.X as a DNA-associated biomarker (Review). World Acad Sci J 3:31
  • Bekeschus S, Clemen R, Haralambiev L, Niessner F, Grabarczyk P, Weltmann KD, Menz J, Stope MB, von Woedtke T, Gandhirajan R, Schmidt A (2021) The plasma-induced leukemia cell death is dictated by the ROS chemistry and the HO-1/CXCL8 axis. IEEE Transactions on Radiation and Plasma Medical Sciences 5:398-411
  • Vasko T, Bonas C, Hoffmann J, Bertram J, Quinete N, Schettgen T, Esser A, Stope MB, Fietkau K, Leijs M, Baron J, Kraus T, Voigt A, Ziegler P (2020) Metabolic activation and toxicological evaluation of polychlorinated biphenyls in Drosophila melanogaster. Sci Rep 10:21587
  • Haralambiev L, Neuffer O, Nitsch A, Kross NC, Bekeschus S, Hinz P, Mustea A, Ekkernkamp A, Gümbel D, Stope MB (2020) Inhibition of angiogenesis by treatment with cold atmospheric plasma as a promising therapeutic approach in oncology. Int J Mol Sci 21:7098
  • Stope MB, Benouahi R, Sander C, Haralambiev L, Nitsch A, Egger E, Mustea A (2020) Protherapeutic effects and inactivation of mammary carcinoma cells by a medical argon plasma device. Anticancer Res 40:6205-6212
  • Rüger M, Kipp E, Schubert N, Schröder N, Pufe T, Stope MB, Kipp M, Blume C, Tauber SC, Brandenburg LO (2020) The formyl peptide receptor agonist Ac2-26 alleviates neuroinflammation in a mouse model of pneumococcal meningitis. J Neuroinflammation 17:325
  • Könsgen D, Klinkmann G, Kaul A, Diesing K, Sehouli J, Braicu I, Sümnig A, Erb HHH, Stope MB, Mustea A (2020) Soluble heat-shock protein 27 in blood serum is a non-invasive prognostic biomarker for ovarian cancer. Eur J Obstet Gynecol Reprod Biol 255:154–159
  • Stope MB (2020) Plasma oncology - Physical plasma as innovative tumor therapy. J Cancer Biol 1:53-56
  • Kletschkus K, Haralambiev L, Mustea A, Bekeschus S, Stope MB (2020) Review of innovative physical therapy methods: introduction to the principles of cold physical plasma. In Vivo 34:3103-3107
  • Ralser DJ, Kumar S, Borisov O, Sarig O, Richard G, Wolf S, Krawitz PM, Sprecher E, Kreiß M, Betz RC (2020) Identification of a founder mutation in KRT14 associated with Naegeli-Franceschetti-Jadassohn-syndrome. Br J Dermatol 183:756-757
  • Kletschkus K, Gelbrich N, Burchardt M, Kramer A, Bekeschus S, Stope MB (2020) Emission of ultraviolet radiation from 220 to 280 nm by a cold physical plasma generating device. Health Phys 119:153-159
  • Jacoby JM, Strakeljahn S, Nitsch A, Bekeschus S, Hinz P, Mustea A, Ekkernkamp A, Tzvetkov MV, Haralambiev L, Stope MB (2020) An innovative therapeutic option for the treatment of skeletal sarcomas: elimination of osteo- and Ewing's sarcoma cells using physical gas plasma. Int J Mol Sci 21:4460
  • Haralambiev L, Bandyophadyay A, Suchy B, Weiss M, Kramer A, Bekeschus S, Ekkernkamp A, Mustea A, Kaderali L, Stope MB (2020) Determination of immediate vs. kinetic growth retardation in physically plasma-treated cells by experimental and modelling data. Anticancer Res 40: 3743-3749
  • Haralambiev L, Nitsch A, Einenkel R, Muzzio DO, Gelbrich N, Burchardt M, Zygmunt M, Ekkernkamp A, Stope MB, Gümbel D (2020) The effect of cold atmospheric plasma on the membrane permeability of human osteosarcoma cells. Anticancer Res 40:841-846
  • Brünnert D, Langer C, Zimmermann L, Bargou RC, Burchardt M, Chatterjee M, Stope MB (2020) The heat shock protein 70 inhibitor VER155008 suppresses the expression of HSP27, HOP and HSP90β and the androgen receptor, induces apoptosis, and attenuates prostate cancer cell growth. J Cell Biochem 121:407-417
  • Haralambiev L, Wien L, Gelbrich N, Lange J, Bakir S, Kramer A, Burchardt M, Ekkernkamp A, Gümbel D, Stope MB (2020) Cold atmospheric plasma inhibits the growth of osteosarcoma cells by induction of apoptosis, independent of the device used. Oncol Lett 19:283-290
  • Haralambiev L, Nitsch A, Jacoby JM, Strakeljahn S, Bekeschus S, Mustea A, Ekkernkamp A, Stope MB (2020) Cold atmospheric plasma treatment of chondrosarcoma cells affects proliferation and cell membrane permeability. Int J Mol Sci 21:2291
  • Daragan G, Hoffmann J,Vasko T, Mustea A, Burchardt M, Kraus T, Stope MB*, Ziegler P* (2019) Dirty deeds done dirt cheap: sensitization of prostate cancer cells to abiraterone treatment using hydroxylated polychlorinated biphenyls. Invest New Drugs 38:541–545
  • Kletschkus K, Haralambiev L, Nitsch A, Pfister F, Klinkmann G, Kramer A, Bekeschus S, Mustea A, Stope MB (2020) The application of a low-temperature physical plasma device operating under atmospheric pressure leads to the production of toxic NO2. Anticancer Res 40:2591-2599
  • Bekeschus S, Ressel V, Freund E, Gelbrich N, Mustea A, Stope MB (2020) Gas plasma-treated prostate cancer cells augment myeloid cell activity and cytotoxicity. Antioxidants 9:323
  • Klümper N, Ralser DJ, Bawden EG, Landsberg J, Zarbl R, Kristiansen G, Toma M,  Ritter M, Hölzel M, Ellinger J, Dietrich D (2020) LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cellcarcinoma. J Immunother Cancer 8:e000552
  • Feil L, Koch A, Utz R, Ackermann M, Barz J, Stope MB, Krämer B, Wallwiener D, Brucker SY, Weiss M (2020) Cancer-selective treatment of cancerous and non-cancerous human cervical cell models by a non-thermally operated electrosurgical argon plasma device. Cancers 12:1037
  • ​​​​​​Weiss M, Barz J, Ackermann M, Utz R, Ghoul A, Weltmann KD, Stope MB, Wallwiener D, Schenke-Layland K, Oehr C, Brucker S, Loskill P (2019) Dose-dependent tissue-level characterization of a medical atmospheric pressure argon plasma jet. ACS Appl Mater Interfaces 11:19841-19853
  • Stope MB, Weiss M, Popp SL, Joffroy C, Buck MB, Mustea A, Brucker S, Wallwiener D, Knabbe C (2019) The pleiotropic factor Y-box binding protein-1 enhances the anti-proliferative efficacy of 4-hydroxytamoxifen and fulvestrant on breast cancer cells in vitro. Eur J Gynaecol Oncol 40:16-18
  • Ralser DJ, Takeuchi H, Fritz G, Basmanav FB, Effern M, Sivalingam S, El-Shabrawi-Caelen L, Degirmentepe EN, Kocatürk E, Singh M, Booken N, Spierings NMK, Schnabel V, Heineke A, Knuever J, Wolf S, Wehner M, Tronnier M, Leverkus M, Tantcheva-Poor I, Wenzel J, Oji V, Has C, Hölzel M, Frank J, Haltiwanger RS, Betz RC (2019) Altered notch signaling in Dowling-Degos disease: Additional mutations in POGLUT1 and further insights into disease pathogenesis. J Invest Dermatol 139:960-964
  • Reuter A, Sckell A, Brandenburg LO, Burchardt M, Kramer A, Stope MB (2019) Overexpression of microRNA-1 in prostate cancer cells modulates the blood vessel system of an in vivo Hen's Egg Test-Chorioallantoic Membrane model. In Vivo 33:41-46
  • Holstein S, Venz S, Junker H, Walther R, Stope MB, Zimmermann U (2019) Nicotinamide N-methyltransferase and its precursor substrate methionine directly and indirectly control malignant metabolism during progresssion of renal cell carcinoma. Anticancer Res 39:5427-5436
  • Knuever J, Persa OD, Illerhaus A, Ralser DJ, Hartmann K, Betz RC, Tantcheva-Poor I (2019): Mast cell activation in Dowling-Degos disease. Br J Dermatol 181:1312-1314
  • Bekeschus S, Schütz C, Nießner F, Wende K, Weltmann KD, Gelbrich N, Woedtke T, Schmidt A, Stope MB (2019) Elevated H2AX phosphorylation observed with kINPen plasma treatment is not caused by ROS-mediated DNA damage but is the consequence of apoptosis. Oxid Med Cell Longev 2019:8535163
  • Nitsch A, Haralambiev L, Einenkel R, Muzzio DO, Zygmunt MT, Ekkernkamp A, Burchardt M, Stope MB (2019) Determination of in vitro membrane permeability by analysis of intracellular and extracellular fluorescein signals in renal cells. In Vivo 33:1767-1771
  • Freund E, Moritz J, Stope MB, Seebauer C, Schmidt A, Bekeschus S (2019) Plasma-derived reactive species shape a differentiation profile in human monocytes. Appl Sci 9:2530
  • Abazid A, Martin B, Choinowski A, McNeill RV, Brandenburg LO, Ziegler P, Zimmermann U, Burchardt M, Erb H, Stope MB (2019) The androgen receptor antagonist enzalutamide induces apoptosis, dysregulates the heat shock protein system, and diminishes the androgen receptor and estrogen receptor β1 expression in prostate cancer cells. J Cell Biochem 120:16711-16722
  • Ahrend H, Daeschlein G, Grove E, Paditz M, Mustea A, Burchardt M, Stope MB (2019) MicroRNA-20a-3p and microRNA-20a-5p exhibit anti-proliferative activities in a melanoma in vitro model. SDRP Journal of Cellular and Molecular Physiology 3:1-7
  • Rottach AM, Ahrend H, Martin B, Walther R, Zimmermann U, Burchardt M, Stope MB (2019) Cabazitaxel inhibits prostate cancer cell growth by inhibition of androgen receptor and heat shock protein expression. World J Urol 37:2137–2145
  • Haralambiev L, Wien L, Gelbrich N, Kramer A, Mustea A, Burchardt M, Ekkernkamp A, Stope MB, Gümbel D (2019) Effects of cold atmospheric plasma on the expression of chemokines, growth factors, TNF superfamily members, interleukins, and cytokines in human osteosarcoma cells. Anticancer Res 39:151-157
  • Gelbrich N, Nitsch A, Burchardt M, Stope MB (2019) Kaltes atmosphärisches Plasma - Antineoplastische Effekte auf Nierenzellkarzinom-Zellen. Urologische Nachrichten 09/2019:5
 

Hochschuldidaktische Publikationen

  • Riedel M, Hennigs A, Dobberkau AM, Riedel C, Bugaj TJ, Nikendei C, Amann N, Karge A, Eisenkolb G, Tensil M, Recker F, Riedel F (2022) The role of gender-specific factors in the choice of specialty training in obstetrics and gynecology: Results from a survey among medical students in Germany. Arch Gynecol Obstet 305:129-137
  • Recker F, Dohmen S, Riedel F, Egger E, Weiss M, Stope MB, Mustea A (2021) Implementation of competence-based teaching and examinations in gynecology and obstetrics within the framework of the new 2020 Medical Licensing Regulation. Gynäkologe 54:515-520
  • Recker F, Riedel F, Stope MB, Mustea A, Weiss M, Jennebach J (2020) Der Masterplan Medizinstudium 2020 und die Implementierung des Nationalen Kompetenzbasierten Lernzielkatalogs Medizin - Chancen und Herausforderungen für die Gynäkologie und Geburtshilfe. Geburtshilfe Frauenheilkunde 80:570-573
  • Recker F, Schulmeyer C, Becker L, Weiss M (2020) PJ-Wahlfach in der Corona-Krise. Frauenarzt 61:311
    • Recker F (2019) Sono4Students - A student sonography project. J Int Educ Pract 2019:18-23
    Unsere Webseite verwendet Cookies.

    Bei Cookies handelt es sich um Textdateien, die im Internetbrowser bzw. vom Internetbrowser auf dem Computersystem des Nutzers gespeichert werden. Ruft ein Nutzer eine Website auf, so kann ein Cookie auf dem Betriebssystem des Nutzers gespeichert werden. Dieser Cookie enthält eine charakteristische Zeichenfolge, die eine eindeutige Identifizierung des Browsers beim erneuten Aufrufen der Website ermöglicht. Wir setzen Cookies ein, um unsere Website nutzerfreundlicher zu gestalten. Einige Elemente unserer Internetseite erfordern es, dass der aufrufende Browser auch nach einem Seitenwechsel identifiziert werden kann.

    Unsere Webseite verwendet Cookies.

    Bei Cookies handelt es sich um Textdateien, die im Internetbrowser bzw. vom Internetbrowser auf dem Computersystem des Nutzers gespeichert werden. Ruft ein Nutzer eine Website auf, so kann ein Cookie auf dem Betriebssystem des Nutzers gespeichert werden. Dieser Cookie enthält eine charakteristische Zeichenfolge, die eine eindeutige Identifizierung des Browsers beim erneuten Aufrufen der Website ermöglicht. Wir setzen Cookies ein, um unsere Website nutzerfreundlicher zu gestalten. Einige Elemente unserer Internetseite erfordern es, dass der aufrufende Browser auch nach einem Seitenwechsel identifiziert werden kann.

    Ihre Cookie-Einstellungen wurden gespeichert.